Vaccinex, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Vaccinex, Inc. (VCNX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $1.11 million as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2025-04-15
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $1.11M.
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $2.91M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $233.00K.
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $2.97M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2024-12-31 | $1.11M 10-K · filed 2025-04-15 |
| 2024-09-30 | $2.91M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $233.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.97M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.53M 10-K · filed 2025-04-15 |
| 2023-09-30 | $127.00K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $1.91M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $3.32M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $6.39M 10-K · filed 2025-04-15 |
| 2022-09-30 | $7.19M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $11.40M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $16.80M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $8.59M 10-K/A · filed 2024-04-25 |
| 2021-09-30 | $13.74M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $22.39M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $29.39M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $10.60M 10-K · filed 2023-03-31 |
| 2020-09-30 | $17.09M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $526.00K 10-Q · filed 2021-08-16 |
| 2020-03-31 | $2.49M 10-Q · filed 2021-05-17 |
| 2019-12-31 | $2.78M 10-K · filed 2022-03-31 |
| 2019-09-30 | $8.58M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $5.28M 10-Q · filed 2020-08-14 |
| 2019-03-31 | $8.94M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $5.62M 10-K · filed 2021-03-31 |
| 2018-09-30 | $11.26M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $4.18M 10-K · filed 2020-03-09 |